Search Orphan Drug Designations and Approvals
|Generic Name:||4-pyridinylmethyl 3(4-chlorophenyl)adamantine carboxamide|
|Orphan Designation:||Treatment of cholangiocarcinoma|
|Orphan Designation Status:||Designated|
|FDA Orphan Approval Status:||Not FDA Approved for Orphan Indication|
|Marketing Approval Date:||N/A|
|Approved Labeled Indication:|
|Exclusivity End Date:||N/A|
RedHill Biopharma Ltd.
21 Ha'arba'a Street
The sponsor address listed is the last reported by the sponsor to OOPD.